In the video, you learn about one study in which researchers found that pot smokers had lower levels of obesity than people who do not smoke pot, and another study that found that a brain chemical with a structure similar to one of the active compounds found in cannabis might actually help people lose weight. The findings are just the latest addition to a growing body of evidence that marijuana may be useful in countering issues related to obesity.
Nature’s Script also sells a pet CBD tincture in 150mg, 300mg, and 1,000mg concentrations. As a general rule of thumb, low-concentration oils are a good option for smaller dogs while larger concentrations may be more suitable for larger breeds – but pet owners should always check with their vet beforehand. In addition to standard shipping, Nature’s Script offers expedited delivery for customers in the contiguous U.S.
Canabidol™ CBD cannabis oil (CBD Oli) is derived from EU approved, UK & US legal, industrial hemp (Cannabis Sativa L.) The active ingredient is Cannabidiol as our products are THC free, meaning that they are non psychoactive so will not get you high. CBD Oil (Cannabidiol) is not scheduled and is found in all hemp products which makes it legal in both the UK and US. Manufactured in England to the highest standards Canabidol™ is now sent out from our United Kingdom distribution centre. You can also purchase our range of CBD oil products direct from one of our many stores across the UK.
Manufacturers have different extraction and plant source methods which cause the CBD oil to have different levels of THC. It’s always advisable to check on the labels to check whether THC levels is less than 0.3 percent. It’s important to note that chances on intoxication are highly unlikely, but some THC found in CBD oils can show up in a drug test.
Using a process called “hybrid-nanoengineering” it is actually possible to get a highly bioavailable and absorbable form of CBD. The way that hybrid-nanoengineering works is that the cannabinoids and terpenoids are extracted from the hemp plant, combined with an Ayurvedic herbal blend and then processed into nanoparticle size. Nanoparticles (1/100 the width of a human hair) are easier for your body to absorb and transport to where they are needed within your body. This means that a hybrid-nanoengineered CBD is over 10x more bioavailable in the body than any other oil based CBD, CBD tincture or CBD capsule, and that just 10mg of a nanoparticle CBD is comparable to 100mg of standard CBD.
Cannabidiol (CBD) is a phytocannabinoid constituent of Cannabis sativa that lacks the psychoactive effects of ∆9-tetrahydrocannabinol (THC). CBD has broad therapeutic properties across a range of neuropsychiatric disorders, stemming from diverse central nervous system actions [11, 12]. In recent years, CBD has attracted increasing interest as a potential anxiolytic treatment [13–15]. The purpose of this review is to assess evidence from current preclinical, clinical, and epidemiological studies pertaining to the potential risks and benefits of CBD as a treatment for anxiety disorders.
In the United States, over three million people suffer from epilepsy – 470,000 of those people are children. Epilepsy is a disorder of the brain that causes seizures – of which there are over thirty different kinds, ranging from mild and infrequent to life-threatening. Not surprisingly, people with epilepsy face significant challenges – from the cost of healthcare to work limitations and social isolation.
Here’s another interesting fact for you: CBD has really strong anti-oxidant and anti-inflammatory properties, due primarily to its effects on your adenosine receptors and cytochrome P-450 and 2C enzymes. When this was first discovered, the US government insisted that cannabis had no medical benefits, but at the same time, they took out patent 6,630,507, which gave them rights to the antioxidant properties of cannabis (which they ironically still claim don’t exist). Incidentally, that patent was not extended to actual oil or capsule extracts of cannabis, so the good ol’ US gummint missed out on some pretty good business opportunities, if you ask me.